<DOC>
	<DOCNO>NCT00793520</DOCNO>
	<brief_summary>The purpose study evaluate effect milnacipran brain process pain patient fibromyalgia assess relationship effect brain activation pattern functional magnetic resonance imaging .</brief_summary>
	<brief_title>Effect Milnacipran Pain Processing Functional Magnetic Resonance Imaging ( fMRI ) Activation Patterns Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>Diagnosis fibromyalgia define 1990 American College Rheumatology ( ACR ) criteria Visual analog pain score 40 90 mm Righthand dominance Suicidal risk Substance Abuse Pulmonary dysfunction Renal impairment Active cardiac disease Autoimmune disease Uncontrolled narrowangle glaucoma Active liver disease Cancer Active peptic ulcer disease history inflammatory bowel disease celiac sprue Unstable endocrine disease Prostatic enlargement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>fibromyalgia</keyword>
	<keyword>milnacipran</keyword>
	<keyword>Forest Laboratories</keyword>
</DOC>